Skip to main content


Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials

Fig. 2

Kaplan-Meier survival estimates of anaemia occurring within 1 week following treatment with artesunate-amodiaquine (AA, blue line), artemether-lumefantrine (AL, green line) or dihydroartemisinin-piperaquine (DHP, yellow line) in children who were non-anaemic pre-treatment. Log-rank statistic = 1.24, P = 0.54. Pooled data from all sentinel sites. The probabilities of progression to anaemia within 1 week post-treatment were similar with all three treatments

Back to article page